{
  "v": 1,
  "requestId": "a855e508-1ebd-4d78-84e3-a65d6800b2a0",
  "chainId": 1,
  "window": {
    "toBlock": 26057952,
    "fromBlock": 26057653,
    "toBlockHash": "0x9eed4463399fbfc0e13ce629737f560e4b8202b2957705e48c48fa2556cf9c1b"
  },
  "answerType": "uint256",
  "answer": "17",
  "figure": "17",
  "definitions": {
    "answer": "the price per share in US dollars, as a whole number",
    "source": "Answer from a reputable public source you actually read (an official institution, league or company site, a wire service, or a major news outlet) and name it. Search the web: this event is recent.",
    "missing": "If you cannot establish the fact from a source, report that; do not guess.",
    "subject": "The question is about a news event from September 2026. The pinned chain and window of this request only timestamp it; the answer is a reported fact about that event, not a reading taken at the pinned block."
  },
  "recipe": {
    "kind": "panel",
    "source": "https://www.globenewswire.com/news-release/2026/09/24/3368818/0/en/adarx-pharmaceuticals-announces-pricing-of-upsized-446-3-million-initial-public-offering.html"
  },
  "notes": "ADARx Pharmaceuticals' September 24, 2026 company press release, distributed by GlobeNewswire, states that the upsized IPO was priced at $17.00 per share. Reuters separately reported $17 per share (https://www.fidelity.com/news/article/default/202609241934RTRSNEWSCOMBINED_TUA5JMMDX_1). The price is expressed in whole US dollars. The pinned chain/window timestamp the request and do not determine this reported news fact."
}